Bristol-Myers Squibb - Company & Market Research Reports

Bristol-Myers Squibb is a pharmaceutical company that develops products for various diseases, such as oncology, virology, cardiovascular diseases, serious mental illness, and immunoscience. The company has delivered 12 new medicines to patients in the past 7 years. It also provides products for Alzheimer's disease, atherosclerosis/thrombosis, hepatitis, HIV/AIDS, solid organ transplant rejection, and a wide variety of other diseases and disorders. Bristol-Myers Squibb was founded in 1990 and is based in Uxbridge, United Kingdom.

Doxorubicin Market By Application (Ovarian, Multiple Myeloma, Kaposi Sarcoma, Leukemia, Bone Sarcoma, Breast, Endometrial, Gastric, Liver, Kidney, Other Cancers) And Segment Forecasts, 2013 - 2024 - Product Thumbnail Image

Doxorubicin Market By Application (Ovarian, Multiple Myeloma, Kaposi Sarcoma, Leukemia, Bone Sarcoma, Breast, Endometrial, Gastric, Liver, Kidney, Other Cancers) And Segment Forecasts, 2013 - 2024

  • Report
  • 84 Pages
From
Bulk Paclitaxel - Global Strategic Business Report - Product Thumbnail Image

Bulk Paclitaxel - Global Strategic Business Report

  • Report
  • 232 Pages
From
Bladder and Ureter Cancer Drug Development Pipeline Review, 2017 - Product Thumbnail Image

Bladder and Ureter Cancer Drug Development Pipeline Review, 2017

  • Report
  • 150 Pages
From
World Market for Anti-Infectives: Antifungals, Antibacterials and Antivirals (Treatments for HIV, HBV, HCV, Urinary Tract, Respiratory, Candidiasis and Other Infections) - Product Thumbnail Image

World Market for Anti-Infectives: Antifungals, Antibacterials and Antivirals (Treatments for HIV, HBV, HCV, Urinary Tract, Respiratory, Candidiasis and Other Infections)

  • Report
  • 220 Pages
From
Global Hepatitis Drug Market & Clinical Trials Insight 2023 - Product Thumbnail Image

Global Hepatitis Drug Market & Clinical Trials Insight 2023

  • Report
  • 550 Pages
From
Interleukin 1 Receptor Associated Kinase 4 (Renal Carcinoma Antigen NY REN 64 or IRAK4 or EC 2.7.11.1) - Pipeline Review, H2 2018 - Product Thumbnail Image

Interleukin 1 Receptor Associated Kinase 4 (Renal Carcinoma Antigen NY REN 64 or IRAK4 or EC 2.7.11.1) - Pipeline Review, H2 2018

  • Report
  • 51 Pages
From
NSCLC Therapeutics in Asia-Pacific Markets to 2019 - Personalized Therapies Focus on Untapped Segment of Squamous Cell Carcinoma to Expand Treatment Pool - Product Thumbnail Image

NSCLC Therapeutics in Asia-Pacific Markets to 2019 - Personalized Therapies Focus on Untapped Segment of Squamous Cell Carcinoma to Expand Treatment Pool

  • Report
  • 109 Pages
From
HIV Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2018-2023 - Product Thumbnail Image

HIV Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2018-2023

  • Report
  • 73 Pages
From
Drug analysis: Erbitux - Product Thumbnail Image

Drug analysis: Erbitux

  • Drug Pipelines
  • 34 Pages
From
HIV Therapeutics in Major Developed Markets to 2019 - Limited Pipeline Efficacy Improvement, Patent Expirations and Stringent Healthcare Spending to Suppress Market Growth - Product Thumbnail Image

HIV Therapeutics in Major Developed Markets to 2019 - Limited Pipeline Efficacy Improvement, Patent Expirations and Stringent Healthcare Spending to Suppress Market Growth

  • Report
  • 170 Pages
From
2018 hepatitis C Drug Development- Pipeline Analysis Report - Product Thumbnail Image

2018 hepatitis C Drug Development- Pipeline Analysis Report

  • Report
  • 200 Pages
From
Global Penicillin and Streptomycin Market Research and Analysis 2015 - 2022 - Product Thumbnail Image

Global Penicillin and Streptomycin Market Research and Analysis 2015 - 2022

  • Report
From
Penicillin and Streptomycin Market - Forecast 2017-2022 - Product Thumbnail Image

Penicillin and Streptomycin Market - Forecast 2017-2022

  • Report
  • 182 Pages
From
Human Immunodeficiency Virus (HIV) Infections (AIDS) - Pipeline Review, H1 2018 - Product Thumbnail Image

Human Immunodeficiency Virus (HIV) Infections (AIDS) - Pipeline Review, H1 2018

  • Report
  • 1005 Pages
From
C-C Chemokine Receptor Type 5 (CHEMR13 or HIV 1 Fusion Coreceptor or CD195 or CCR5) - Pipeline Review, H1 2018 - Product Thumbnail Image

C-C Chemokine Receptor Type 5 (CHEMR13 or HIV 1 Fusion Coreceptor or CD195 or CCR5) - Pipeline Review, H1 2018

  • Report
  • 70 Pages
From
Ocular Cancer Drug Development Pipeline Review, 2018 - Product Thumbnail Image

Ocular Cancer Drug Development Pipeline Review, 2018

  • Report
  • 63 Pages
From
PharmaPoint: Human Immunodeficiency Virus (HIV) - Global Drug Forecast and Market Analysis to 2025 - Product Thumbnail Image

PharmaPoint: Human Immunodeficiency Virus (HIV) - Global Drug Forecast and Market Analysis to 2025

  • Report
  • 365 Pages
From
HIV Attachment Inhibitor -Pipeline Insight, 2018 - Product Thumbnail Image

HIV Attachment Inhibitor -Pipeline Insight, 2018

  • Drug Pipelines
  • 60 Pages
From
Hepatitis A Virus Cellular Receptor 2 (T Cell Immunoglobulin And Mucin Domain Containing Protein 3 or T Cell Immunoglobulin Mucin Receptor 3 or T Cell Membrane Protein 3 or CD366 or HAVCR2) - Pipeline Review, H1 2018 - Product Thumbnail Image

Hepatitis A Virus Cellular Receptor 2 (T Cell Immunoglobulin And Mucin Domain Containing Protein 3 or T Cell Immunoglobulin Mucin Receptor 3 or T Cell Membrane Protein 3 or CD366 or HAVCR2) - Pipeline Review, H1 2018

  • Report
  • 63 Pages
From
Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Analysis By Drug Class And Segment Forecasts, 2014 - 2025 - Product Thumbnail Image

Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Analysis By Drug Class And Segment Forecasts, 2014 - 2025

  • Report
  • 75 Pages
From
Loading Indicator
adroll